title: Interaction of noradrenaline, NPY and VIP with the neurogenic cholinergic response of the rat uterine cervix in vitro.
abstract: Quantitative pharmacological studies were performed on isolated uterine cervix which was obtained from oophorectomized and oestrogen-treated rats and therefore showed no spontaneous contractility. The concentration-response curves to ACh and carbacholine were to a varying degree depressed and right-shifted in the presence of NA, but not NPY or VIP. The electrically induced cholinergic contraction was potentiated in tissues from animals pretreated with reserpine or 6-OHDA, but only at high stimulation frequencies. Histochemically, both sympatholytics abolished NA from the cervical fibres, whereas immunoreactive NPY was still encountered. Tyramine in the organ bath reduced the contraction amplitude during electrical nerve stimulation concentration-dependently by a beta-adrenoceptor-sensitive mechanism. In the presence of neostigmine the amplitude was reduced by NA, but not by NPY or VIP, which, on the other hand, had an inhibitory effect in the absence of neostigmine. The results offer further support for the view that, although the cervical smooth muscle cells are equipped with adrenoceptors, the neurogenic motor response at low stimulation frequencies (around 3 HZ) is mainly cholinergic. It appears that neurally released NA is able to influence these muscle cells primarily at high frequencies. There is no clear-cut evidence that the inhibitory effects of neural NPY or VIP on the cervix of spayed, oestrogen-treated rats are mediated by postjunctional receptors.
authors.affiliation: Department of Obstetrics/Gynecology, University of Lund, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Stjernquist
authors.forename: C
authors.initials: C
authors.lastname: Owman
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000320:Adrenergic Fibers / Q000187:drug effects; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002584:Cervix Uteri / Q000187:drug effects* / Q000294:innervation; D004558:Electric Stimulation; D005260:Female; D005455:Fluorescent Antibody Technique; D066298:In Vitro Techniques; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation; D009478:Neuropeptide Y / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011950:Receptors, Cholinergic / Q000187:drug effects*; D014590:Uterine Contraction / Q000187:drug effects*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
chemical_list: D009478:Neuropeptide Y; D011950:Receptors, Cholinergic; D014660:Vasoactive Intestinal Peptide; D002217:Carbachol; D000109:Acetylcholine; D009638:Norepinephrine